Citation Tools

Download PDFPDF

350 Phase 2 trial of a DNA vaccine with pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)
Free

Download to a citation manager

Cite this article as:
McNeel D, Eickhoff J, Wargowski E, et al
350 Phase 2 trial of a DNA vaccine with pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)